Search Results - "Landman, Allison"

Refine Results
  1. 1

    Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance by Das Thakur, Meghna, Salangsang, Fernando, Landman, Allison S., Sellers, William R., Pryer, Nancy K., Levesque, Mitchell P., Dummer, Reinhard, McMahon, Martin, Stuart, Darrin D.

    Published in Nature (London) (14-02-2013)
    “…BRAF inhibitors such as vemurafenib have shown promising effects in patients with BRAF-mutant melanomas, but the tumours generally develop resistance;…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Mutationally-activated PI3’-kinase-α promotes de-differentiation of lung tumors initiated by the BRAFV600E oncoprotein kinase by van Veen, J Edward, Scherzer, Michael, Boshuizen, Julia, Chu, Mollee, Liu, Annie, Landman, Allison, Green, Shon, Trejo, Christy, McMahon, Martin

    Published in eLife (27-08-2019)
    “…Human lung adenocarcinoma exhibits a propensity for de-differentiation, complicating diagnosis and treatment, and predicting poorer patient survival. In…”
    Get full text
    Journal Article
  4. 4
  5. 5

    SSO 2024 by Landman, Allison

    Published in The lancet oncology (01-05-2024)
    “…In a secondary analysis of the phase 2 adaptively randomised I-SPY2 trial presented by Judy C Boughey (Mayo Clinic, Rochester, MN, USA), outcomes were compared…”
    Get full text
    Journal Article
  6. 6

    2023 ASCO Annual Meeting by Landman, Allison

    Published in The lancet oncology (01-07-2023)
    “…Neoadjuvant treatment in lung cancer Combining neoadjuvant pembrolizumab and ramucirumab in patients with PD-L1-positive, resectable, stage IB–IIIA…”
    Get full text
    Journal Article
  7. 7

    Mechanisms of Rad52-Independent Spontaneous and UV-Induced Mitotic Recombination in Saccharomyces cerevisiae by Coïc, Eric, Feldman, Taya, Landman, Allison S, Haber, James E

    Published in Genetics (Austin) (01-05-2008)
    “…In wild-type diploid cells, heteroallelic recombination between his4A and his4C alleles leads mostly to His+ gene conversions that have a parental…”
    Get full text
    Journal Article
  8. 8

    2021 World Conference on Lung Cancer by Landman, Allison

    Published in The Lancet. Oncology (01-10-2021)
    “…POSEIDON Melissa Johnson (Sarah Cannon Research Institute, Nashville, TN, USA) presented results from a randomised, open-label, phase 3 study of 1013 patients…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    ESTRO 2020 Online Congress by Landman, Allison

    Published in The Lancet. Oncology (01-01-2021)
    “…In a study presented by Thierry De Baère (Institut Gustave Roussy, Villejuif, France), NBTXR3 at four dose levels (10%, 15%, 22%, and 33% of tumour volume) was…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    The G1 Cyclin Cln3 Promotes Cell Cycle Entry via the Transcription Factor Swi6 by Wijnen, Herman, Landman, Allison, Futcher, Bruce

    Published in Molecular and Cellular Biology (01-06-2002)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  11. 11

    Global cancer surgery: a vital service to eliminate false economy by Landman, Allison, Collingridge, David

    Published in The lancet oncology (01-12-2023)
    “…8 years on from publication of the first surgery Commission in The Lancet Oncology, some progress has been made, such as the launch of WHO's Breast Health…”
    Get full text
    Journal Article
  12. 12

    49th SIOP Congress by Landman, Allison

    Published in The Lancet. Oncology (01-11-2017)
    “…Omitting radiotherapy for Wilm's tumour Xiaofei Sun (Sun Yat Sen University Cancer Center, Guangzhou, China) presented interim results from a multicentre,…”
    Get full text
    Journal Article Conference Proceeding
  13. 13

    European Society of Medical Oncology 2016 Congress by Landman, Allison

    Published in The Lancet. Oncology (01-11-2016)
    “…Selinexor in gynaecological cancer Treatment with selinexor, a first-in-class inhibitor of the nuclear export protein XPO1, led to disease control and overall…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    2016 ASCO Gastrointestinal Cancers Symposium by Landman, Allison

    Published in The lancet oncology (01-03-2016)
    “…GATSBY trial Results from the adaptive phase 2/3 randomised GATSBY trial presented by Yoon-Koo Kang (University of Ulsan College of Medicine, Seoul, South…”
    Get full text
    Journal Article
  15. 15

    Treating childhood cancer: a necessity not a choice by Landman, Allison, Collingridge, David

    Published in The lancet oncology (01-04-2020)
    “…Owing to population growth and inequitable access to cancer care, 80% of the global cancer burden–in terms of both incidence and mortality is estimated to fall…”
    Get full text
    Journal Article
  16. 16

    16th World Conference on Lung Cancer by Landman, Allison

    Published in The Lancet. Oncology (01-10-2015)
    “…Suresh Ramalingam (Atlanta, GA, USA) presented data for an expansion cohort of AURA in which 60 patients with treatment-naive EGFR mutation-positive advanced…”
    Get full text
    Journal Article Conference Proceeding
  17. 17

    Working together to reduce the burden of pancreatic cancer by Landman, Allison, Feetham, Laura, Stuckey, Daniel

    Published in The lancet oncology (01-03-2020)
    “…The global incidence of pancreatic cancer in 2017 was 5·7 per 100 000 person-years, up from 5·0 per 100 000 person-years in 1990; the number of deaths also…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Mutationally-activated PI3'-kinase-α promotes de-differentiation of lung tumors initiated by the BRAF V600E oncoprotein kinase by van Veen, J Edward, Scherzer, Michael, Boshuizen, Julia, Chu, Mollee, Liu, Annie, Landman, Allison, Green, Shon, Trejo, Christy, McMahon, Martin

    Published in eLife (27-08-2019)
    “…Human lung adenocarcinoma exhibits a propensity for de-differentiation, complicating diagnosis and treatment, and predicting poorer patient survival. In…”
    Get full text
    Journal Article
  20. 20

    The G(1) cyclin Cln3 promotes cell cycle entry via the transcription factor Swi6 by Wijnen, Herman, Landman, Allison, Futcher, Bruce

    Published in Molecular and cellular biology (01-06-2002)
    “…In Saccharomyces cerevisiae (budding yeast), commitment to cell division in late G(1) is promoted by the G(1) cyclin Cln3 and its associated cyclin-dependent…”
    Get full text
    Journal Article